459 related articles for article (PubMed ID: 8275483)
1. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
[TBL] [Abstract][Full Text] [Related]
2. The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.
Grégoire V; Van NT; Stephens LC; Brock WA; Milas L; Plunkett W; Hittelman WN
Cancer Res; 1994 Dec; 54(23):6201-9. PubMed ID: 7954467
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation.
Grégoire V; Hunter N; Brock WA; Milas L; Plunkett W; Hittelman WN
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):363-71. PubMed ID: 7928463
[TBL] [Abstract][Full Text] [Related]
5. Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.
Grégoire V; Hunter NR; Brock WA; Hittelman WN; Plunkett W; Milas L
Radiat Res; 1996 Nov; 146(5):548-53. PubMed ID: 8896581
[TBL] [Abstract][Full Text] [Related]
6. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
7. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L
Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694
[TBL] [Abstract][Full Text] [Related]
8. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW
Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Milas L; Hunter NR; Mason KA; Kurdoglu B; Peters LJ
Cancer Res; 1994 Jul; 54(13):3506-10. PubMed ID: 7912167
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice.
Papadopoulou MV; Ji M; Ji X; Bloomer WD; Hollingshead MG
Cancer Chemother Pharmacol; 2002 Dec; 50(6):501-8. PubMed ID: 12451478
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
Dexter DL; Lee ES; Bliven SF; Glicksman AS; Leith JT
Cancer Res; 1984 Nov; 44(11):4942-6. PubMed ID: 6488157
[TBL] [Abstract][Full Text] [Related]
13. Effect of intra-peritoneal fludarabine on rat spinal cord tolerance to fractionated irradiation.
Grégoire V; Ruifrok AC; Price RE; Brock WA; Hittelman WN; Plunkett WK; Ang KK
Radiother Oncol; 1995 Jul; 36(1):50-5. PubMed ID: 8525025
[TBL] [Abstract][Full Text] [Related]
14. CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Mason KA; Neal R; Hunter N; Ariga H; Ang K; Milas L
Radiother Oncol; 2006 Aug; 80(2):192-8. PubMed ID: 16905212
[TBL] [Abstract][Full Text] [Related]
15. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
Sun JR; Brown JM
Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel enhances tumor radioresponse in vivo.
Mason KA; Hunter NR; Milas M; Abbruzzese JL; Milas L
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2431-8. PubMed ID: 9815644
[TBL] [Abstract][Full Text] [Related]
17. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumors.
Fenton BM; Paoni SF; Ding I
Cancer Res; 2004 Aug; 64(16):5712-9. PubMed ID: 15313911
[TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent therapeutic gain from the combination of fractionated irradiation and cis-diamminedichloroplatinum (II) in C3H/Km mouse model systems.
Kanazawa H; Rapacchietta D; Kallman RF
Cancer Res; 1988 Jun; 48(11):3158-64. PubMed ID: 2966671
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2).
Jürgenliemk-Schulz IM; Renes IB; Rutgers DH; Everse LA; Bernsen MR; Den Otter W; Battermann JJ
Radiat Oncol Investig; 1997; 5(2):54-61. PubMed ID: 9303058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]